Induction of apoptosis and chemosensitization by the histone deacetylase inhibitor trichostatin in hepatocellular carcinoma cells: Molecular analysis and RKIP levels

Forum on Immunopathological Diseases and Therapeutics

Volumn 2, Issue 2, 2011, Pages 127-135

  Inguglia, Luigi ^a   Notarbartolo, Monica ^a   Poma, Paola ^a   Labbozzetta, Manuela ^a   D'Alessandro, Natale ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Apoptosis; Chemosensitization; Gene expression; Hepatocellular carcinoma; Histone deacetylase inhibitor; Raf 1 kinase inhibitor protein; Trichostatin; Yin Yang 1

Indexed keywords

DOXORUBICIN; HISTONE DEACETYLASE INHIBITOR; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR YY1; TRICHOSTATIN A;

APOPTOSIS; CARCINOMA CELL; CELL GROWTH; CHEMOSENSITIZATION; CONFERENCE PAPER; CONTROLLED STUDY; DENSITOMETRY; DOWN REGULATION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; EPIGENETICS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOLECULAR DYNAMICS; PRIORITY JOURNAL; UPREGULATION;

EID: 79958260653     PISSN: 21518017     EISSN: 21518025     Source Type: Journal    
DOI: 10.1615/ForumImmunDisTher.v2.i2.40     Document Type: Conference Paper

References (28)

1. El-Seraq HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcino-genesis. Gastroenterology. 2007;132:2557-76. (Pubitemid 46890874)
2. Sandhu DS, Tharavil VS, Lai JP, Roberts LR. Treatment options for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2008;2:81-92.
3. Wong CM, Ng IO. Molecular pathogenesis of hepatocellular carcinoma. Liver Int. 2008;28:160-74. (Pubitemid 351201031)
4. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378-90.
5. Yoshida T, Hisamoto T, Akiba J, Koga H, Nakamura K, Tokunaga Y, Hanada S, Kumemura H, Maeyama M, Harada M, Ogata H, Yano H, Kojiro M, Ueno T, Yoshimura A, Sata M. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene. 2006;25:6056-66. (Pubitemid 44562404)
6. Calvisi DF, Pinna F, Meloni F, Ladu S, Pellegrino R, Sini M, Daino L, Simile MM, De Miglio MR, Virdis P, Frau M, Tomasi ML, Seddaiu MA, Muroni MR, Feo F, Pascale RM. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. Cancer Res. 2008;68:4192-200.
7. Schuierer MM, Bataille F, Weiss TS, Hellerbrand C, Bosserhoff AK. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep. 2006;16:451-6.
8. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology. 2006;131:1208-17. (Pubitemid 44498689)
9. D'Alessandro N, Giannitrapani L, Labbozzetta M, Poma P, Inguglia L, Florena AM, Porcasi R, Cervello M, Montalto G, Notarbartolo N. Yin Yang 1 and Raf-1 kinase inhibitor protein status in hepatocellular carcinoma: future perspectives. Forum Immunol Dis Ther. 2010;1:97-114.
10. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 1999;401: 173-7. (Pubitemid 29436321)
11. Tang H, Park S, Sun SC, Trumbly R, Ren G, Tsung E, Yeung KC. RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Lett. 2010:584:662-8.
12. Klysik J, Theroux SJ, Sedivy JM, Moffit JS, Boekelheide K. Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal. 2008;20:1-9. (Pubitemid 350138364)
13. Eves EM, Shapiro P, Naik K, Klein UR, Trakul N, Rosner MR. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell. 2006;23:561-74. (Pubitemid 44205493)
14. Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem. 2004;27:17515-23. (Pubitemid 38560515)
15. Jazirehi AR, Bonavida B. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention. Oncogene. 2005;24:2121-43. (Pubitemid 40516580)
16. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A. Loss of raf-1 kinase inhibitor protein expression is associ ated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol. 2007;127: 820-7.
17. Al-Mulla F, Hagan S, Al-Ali W, Jacob SP, Behbehani AI., Bitar MS, Dallol A, Kolch W. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol. 2008;61: 524-9. (Pubitemid 351518239)
18. Okita K, Matsukawa N, Maki M, Nakazawa H, Katada E, Hattori M, Akatsu H, Borlongan CV, Ojika K. Analysis of DNA variations in promoter region of HCNP gene with Alzheimer's disease. Biochem Biophys Res Commun. 2009;379:272-6.
19. Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA, Bonavida B. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol. 2007;179:5441-53.
20. Rikimaru T, Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, Shimada M, Maehara Y. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology. 2007;72:69-74. (Pubitemid 350249132)
21. Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK, Lee MO. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene. 2008;27:3405-13. (Pubitemid 351769313)
22. Venturelli S, Armeanu S, Pathil A, Hsieh CJ, Weiss TS, Vonthein R, Wehrmann M, Gregor M, Lauer UM, Bitzer M. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma. Cancer. 2007;109:2132-41. (Pubitemid 46744210)
23. Carlisi D, Vassallo B, Lauricella M, Emanuele S, D'Anneo A, Di Leonardo E, Di Fazio P, Vento R, Tesoriere G. Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. Int J Oncol. 2008;32:177-84. (Pubitemid 351176076)
24. Berenbaum MC.What is synergy? Pharmacol Rev. 1989;41:93-141. (Pubitemid 20019599)
25. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells: analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005;224:53-65. (Pubitemid 40720367)
26. Cervello M, Notarbartolo M, Landino M, Cusimano A, Virruso L, Montalto G, D'Alessandro N. Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepato-carcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine? Eur J Cancer. 2001;37:512-9. (Pubitemid 32232117)
27. Rosato RR, Maggio SC, Almenara JA, Payne SG, Atadja P, Spiegel S, Dent P, Grant S. The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide. Mol Pharmacol. 2006;69:216-25. (Pubitemid 43048908)
28. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 2003;3:46-54. (Pubitemid 37328886)